Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | ATP4A | P20648 | 11/20 | 0.33 |
| ▸ | ATP4B | P51164 | 11/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | RARB | P10826 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14599679 | 0.82 | STAT3 (0.39) | L3MBTL1TDP1 | |
| SCHEMBL14599678 | 0.82 | ATP4A (0.38) | L3MBTL1CYP2D6CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL14599686 | 0.79 | TDP1 (0.36) | L3MBTL1TDP1 | |
| SCHEMBL14599698 | 0.77 | FFAR1 (0.39) | L3MBTL1TDP1 | |
| SCHEMBL14599706 | 0.77 | STAT3 (0.38) | L3MBTL1ATP4AATP4BKDM4ENPC1 | |
| SCHEMBL14629725 | 0.76 | TDP1 (0.34) | L3MBTL1TDP1 | |
| SCHEMBL14599676 | 0.75 | STAT3 (0.44) | L3MBTL1ATP4AATP4BKDM4ENPC1 | |
| Pyridine SCHEMBL28010654 | 0.74 | CYP2D6 (0.49) | L3MBTL1CYP2D6CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL8031578 | 0.74 | TERT (0.49) | L3MBTL1CYP2D6CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL12190732 | 0.74 | TERT (0.49) | L3MBTL1CYP2D6CYP19A1CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070015742-A1 | Porphyrin derivatives | YAHIOGLU GOKHAN | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070015742-A1 | Porphyrin derivatives | SCO2, CBR3, CBR1 | L3MBTL1 3006/4885TDP1 4330/4885CYP2D6 2544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.